Cargando…
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Liver fibrosis represents a common outcome of most chronic liver diseases. Advanced fibrosis leads to cirrhosis for which no effective treatment is available except liver transplantation. Because of the limitations of liver transplantation, alternative therapeutic strategies are an urgent need to fi...
Autores principales: | Cao, Yan, Ji, Chenbo, Lu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347778/ https://www.ncbi.nlm.nih.gov/pubmed/32775363 http://dx.doi.org/10.21037/atm.2020.02.119 |
Ejemplares similares
-
Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020) -
Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases
por: Wang, Yu, et al.
Publicado: (2020) -
The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020) -
Hurdles to uptake of mesenchymal stem cells and their progenitors in therapeutic products
por: Childs, Peter G., et al.
Publicado: (2020) -
Bovine tongue epithelium-derived cells: A new source of bovine mesenchymal stem cells
por: Lee, Jienny, et al.
Publicado: (2020)